Financhill
Back

Lyell Immunopharma Vs. Strategy Industry Stock Comparison

Sell
28

LYEL
Lyell Immunopharma

Last Price:
$0.66
Seasonality Move:
12.1%
Sell
42

MSTR
Strategy

Last Price:
$262.56
Seasonality Move:
-7.07%
Sell
28
Lyell Immunopharma (LYEL) is a Sell

Is Lyell Immunopharma a Buy, Sell or Hold?

  • The current Lyell Immunopharma [LYEL] share price is $0.67. The Score for LYEL is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • LYEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Strategy (MSTR) is a Sell

Is Strategy a Buy, Sell or Hold?

  • The current Strategy [MSTR] share price is $260.59. The Score for MSTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • MSTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LYEL Stock Price Chart

What is Lyell Immunopharma's stock price today?

  • The Lyell Immunopharma share price today is $0.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.

MSTR Stock Price Chart

What is Strategy's stock price today?

  • The Strategy share price today is $260.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 50.28 Buy
Chaikin Money Flow: -390836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.7) Buy
Bollinger Bands (100): (0.59 - 1.05) Sell

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -16.58 Sell
Relative Strength Index (14 RSI): 42.2 Sell
Chaikin Money Flow: 18568120 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (271.71 - 339.13) Sell
Bollinger Bands (100): (258.91 - 384.07) Sell

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.7 Sell
20-day SMA: 0.65 Buy
50-day SMA: 0.63 Buy
200-day SMA: 1.26 Sell
8-day EMA: 0.7 Sell
20-day EMA: 0.67 Sell
50-day EMA: 0.69 Sell
200-day EMA: 1.17 Sell

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 272.75 Sell
20-day SMA: 297.16 Sell
50-day SMA: 325.25 Sell
200-day SMA: 235.44 Buy
8-day EMA: 280.39 Sell
20-day EMA: 294.66 Sell
50-day EMA: 313.35 Sell
200-day EMA: 251.3 Buy

Lyell Immunopharma Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.16 per share.

Strategy Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.

Lyell Immunopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Strategy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):